Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04620070
Other study ID # NL73073.078.20
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 15, 2021
Est. completion date July 1, 2026

Study information

Verified date October 2023
Source Erasmus Medical Center
Contact Dinis Reis Miranda, MD.PhD
Phone +31107040704
Email d.dosreismiranda@erasmusmc.nl
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Hypothesis: Implantation of on-scene ECPR by the HEMS teams in patients with sustained out-of-hospital cardiac arrest, results in the rapid return of circulation and, thus, improved survival and less neurological impairment, which is associated with lower health care costs.


Description:

Rationale: Approximately half of all cardiac arrest patients achieve return of spontaneous circulation (ROSC) within 10 minutes. However, If ROSC is not achieved within 20 minutes, favourable neurological outcome is rare. Currently, patients without ROSC at scene die at scene, or are transported (while still in cardiac arrest) to the hospital. In the hospital, advanced life support is continued, or, when presented to selected hospitals capable for this strategy, patients receive Extracorporeal CardioPulmonary Resuscitation (ECPR). ECPR is a strategy in which a miniaturized heart-lung machine (similar to that used in open-heart surgery) is attached to the patient. Nowadays, the greatest drawback transporting OHCA patients with refractory arrest to the hospital are the low quality of thorax compression during transport and long time needed to arrive in the hospital, in part because not all hospitals are able to provide this treatment. In the Netherlands, Helicopter Emergency Medical Services (HEMS) deliver highly specialized medical care to trauma and non-trauma patients, covering the entire country. Hypothesis: Implantation of on-scene ECPR by the HEMS teams in patients with sustained out-of-hospital cardiac arrest, results in the rapid return of circulation and, thus, improved survival and less neurological impairment, which is associated with lower health care costs. Objective: To improve survival to hospital discharge and costs/QALY in young patients with OHCA by decreasing the time in cardiac arrest by initiating ECPR on scene.


Recruitment information / eligibility

Status Recruiting
Enrollment 390
Est. completion date July 1, 2026
Est. primary completion date July 1, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - - Age between 18 and 50 years, known or as estimated at inclusion by the HEMS physician. - Witnessed arrest (last seen well <5 min), OR signs of life (gasping, movement) - Initial rhyme is VT/VF OR Suspected of having a pulmonary embolism - Refractory cardiac arrest lasting longer than 20 minutes and shorter than 45 min If age is not exactly known at inclusion and is estimated by the HEMS physician between 18 and 50 years but finally the patient appears to be younger or older, the patient will not be excluded. Exclusion Criteria: - - CO2 et<1.2 kPa (10 mmHg) during CPR - No clear echographic visualisation of either the femoral artery or the femoral vein. - Expected time from collapse to arrival at an ECPR center with a direct available ECPR team is less than 30 min. The following patients will be withdrawn after initial inclusion as soon as the following information becomes available: - Known malignancy - Known intracranial haemorrhage/ischemia <6 weeks - Care dependent for daily activities before arrest - Patients with a "do not resuscitate" order, which was not known at time of the arrest. - Refusal of deferred consent by the next of kin or by the patient himself to use the data. Deferred consent will not be asked to relatives of patients who die in scene, but are included in the study.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
ECPR
Application of prehospital ECPR

Locations

Country Name City State
Netherlands Amsterdam UMC Amsterdam
Netherlands UMCG Groningen
Netherlands Radboud Nijmegen
Netherlands ErasmusMC Rotterdam

Sponsors (10)

Lead Sponsor Collaborator
Erasmus Medical Center Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Amphia ziekenhuis, Catharina Ziekenhuis Eindhoven, Haga Hospital, Isala, Leiden University Medical Center, Radboud University Medical Center, St. Antonius Hospital, University Medical Center Groningen

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hospital Survival (% patients surviving hospital discharge) Hospital discharge (on average 6 weeks)
Primary Favourable neurological outcome (CPC 1-2) (% of patients at least performing daily life activities independent) 6 months after cardiac arrest
Primary Favourable neurological outcome (CPC 1-2) (% of patients at least performing daily life activities independent) 12 months after cardiac arrest
Primary Costs/QALY Costs related to prehospital ECPR per Quality Adjusted Life Year (Quality of Life assessed by EQ-5D questionnaire). Stated as incremental costs in Euro's ranging from 0-100.000 euro) 6 months after cardiac arrest
Primary Costs/QALY Costs related to prehospital ECPR per Quality Adjusted Life Year (Quality of Life assessed by EQ-5D questionnaire). Stated as incremental costs in Euro's ranging from 0-100.000 euro) 12 months after cardiac arrest
Secondary Survival prehospital ECPR vs ECPR at the hospital vs no ECPR Hospital discharge (on average 6 weeks after cardiac arrest)
Secondary survival OHCA treated by paramedic (historic control) only vs HEMS physician Hospital discharge (on average 6 weeks after cardiac arrest)
See also
  Status Clinical Trial Phase
Recruiting NCT06048068 - Removing Surrogates' Uncertainty to Reduce Fear and Anxiety After Cardiac Events N/A
Recruiting NCT05558228 - Accuracy of Doppler Ultrasound Versus Manual Palpation of Pulse in Cardiac Arrest
Completed NCT03685383 - Cytokine Adsorption in Post-cardiac Arrest Syndrome in Patients Requiring Extracorporeal Cardiopulmonary Resuscitation N/A
Completed NCT04619498 - Effectiveness of an Interactive Cognitive Support Tablet App to Improve the Management of Pediatric Cardiac Arrest N/A
Completed NCT04584645 - A Digital Flu Intervention for People With Cardiovascular Conditions N/A
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Withdrawn NCT02352350 - Lactate in Cardiac Arrest N/A
Completed NCT03024021 - Cerebral Oxymetry and Neurological Outcome in Therapeutic Hypothermia
Completed NCT02247947 - Proteomics to Identify Prognostic Markers After CPR and to Estimate Neurological Outcome
Completed NCT02275234 - Care After Resuscitation
Completed NCT01972087 - Simulation Training to Improve 911 Dispatcher Identification of Cardiac Arrest N/A
Completed NCT01944605 - Intestinal Ischemia as a Stimulus for Systemic Inflammatory Response After Cardiac Arrest N/A
Completed NCT01936597 - Prospective Study of 3 Phone Assistance Strategies to Achieve a Continuous Cardiac Massage N/A
Active, not recruiting NCT01239420 - Norwegian Cardio-Respiratory Arrest Study
Completed NCT01191736 - Ultra-Brief Versus Brief Hands Only CPR Video Training With and Without Psychomotor Skill Practice N/A
Completed NCT00878644 - Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-OH [Out of Hospital] Trial Phase 3
Completed NCT00880087 - Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-IH [In Hospital] Trial N/A
Completed NCT00729794 - Vasopressin, Epinephrine, and Steroids for Cardiac Arrest Phase 3
Recruiting NCT00441753 - Cerebral Bloodflow and Carbondioxide Reactivity During Mild Therapeutic Hypothermia in Patients After Cardiac Arrest N/A
Completed NCT00347477 - Fluid Shifts in Patients Treated With Therapeutic Hypothermia After Cardiac Arrest Phase 3